5 research outputs found

    Resveratrol-Induced Xenophagy Promotes Intracellular Bacteria Clearance in Intestinal Epithelial Cells and Macrophages

    Get PDF
    Autophagy is a lysosomal degradation process that contributes to host immunity by eliminating invasive pathogens and the modulating inflammatory response. Several infectious and immune disorders are associated with autophagy defects, suggesting that stimulation of autophagy in these diseases should be beneficial. Here, we show that resveratrol is able to boost xenophagy, a selective form of autophagy that target invasive bacteria. We demonstrated that resveratrol promotes in vitro autophagy-dependent clearance of intracellular bacteria in intestinal epithelial cells and macrophages. These results were validated in vivo using infection in a transgenic GFP-LC3 zebrafish model. We also compared the ability of resveratrol derivatives, designed to improve the bioavailability of the parent molecule, to stimulate autophagy and to induce intracellular bacteria clearance. Together, our data demonstrate the ability of resveratrol to stimulate xenophagy, and thereby enhance the clearance of two invasive bacteria involved life-threatening diseases, Salmonella Typhimurium and Crohn's disease-associated Adherent-Invasive Escherichia coli. These findings encourage the further development of pro-autophagic nutrients to strengthen intestinal homeostasis in basal and infectious states

    Étude des interactions de la sĂ©lĂ©noproteine P et de la vasopressine disĂ©lĂ©niĂ©e en prĂ©sence d’auranofine et de cisplatine

    No full text
    Selenium is known to be an essential trace element with antioxidant activities. Its physiological role is mainly due to its co-translational incorporation into selenoproteins as selenocysteine (SeCys), referred to as the 21st amino acid. selenoprotein P (SELENOP) is the major selenoprotein in plasma with up to 10 SeCys in its sequence. Because of the chemical complexity of the serum matrix, the low abundance of selenoprotein P, and the occurrence of its putative multiple isoforms and post-translational modifications (e.g., glycosylation, Se-S and Se-Se bridges), the characterization of selenoprotein P requires the protein selective pre-concentration and custom-designed optimization of analytical methodology. Containing 10 SeCys residues, SELENOP is a potential preferential target for metallodrugs such as auranofin and cisplatin. The interactions have not been studied yet at the molecular level, despite considerable evidence that free selenols are biding sites for auranofin in another selenoprotein, thioredoxin reductase. The lack of studies of selenoprotein P is likely due to the fact that the protein cannot be heterologously expressed and needs to be purified from serum where it is present at ng/g concentration (as Se). This thesis presents the development of the method of purification of SELENOP from human serum using two-dimensional affinity chromatography. The two chromatographic steps using immobilized metal (cobalt) affinity and heparin affinity chromatography allowed the purification of SELENOP with excellent selectivity. The subsequent characterization of the purified SELENOP by nanoHPLC - electrospray ESI MS/MS allowed accounting for almost all selenocysteine-containing tryptic SELENOP peptides and the elucidation of some glycosylation sites. In addition, the recovery of selenium incorporated in SELENOP was quantitatively monitored, for the first time, at each step of the purification procedure. The recovery of SELENOP was 14% after all the purification steps. Selenium present in SELENOP was found to account for 35% of total selenium in serum.The purification of SELENOP allowed the first study of its interactions with auranofin and cisplatin containing, Au(I) and Pt(II), respectively. The protein metalation was observed after incubation of SELENOP with both metallodrugs. After digestion with trypsin, Au and Pt modifications were observed on the resulting peptides. Either in the case of auranofin and cisplatin, two SELENOP peptides were found to form Au or Pt adducts by Cy and SeCys binding (MS/MS characterization). These four peptides, specific to SELENOP, displayed different sequences.Moreover, to comparatively study the interactions of the Se-Se and S-S bridges with metallodrugs, vasopressin and its di-selenide analogues were used as model peptides. Their reactivity with auranofin and its strict analogues was investigated by LC-electrospray MS/MS. Evidence was obtained of the possible cleavage of the S-S and Se-Se bridges induced by Au(I) in the absence of reducing agents, in contrast to the previous studies requiring a prior reduction of the Se-Se bond to make it react with Au(I) compounds. In addition, we found that at high temperatures (70 °C), the sulfur and selenium atoms were metallated with the preferential binding of gold to selenium, the reaction not taking place under physiological conditions (37 °C).L'un des objectifs de cette thĂšse a Ă©tĂ© de revisiter les schĂ©mas d'isolement de SELENOP rapportĂ©s ailleurs afin de dĂ©velopper une mĂ©thode capable de produire des quantitĂ©s suffisantes de SELENOP pour produire des signaux spĂ©cifiques aux espĂšces de Se mesurables pour des Ă©tudes par spectromĂ©trie de masse des interactions de SELENOP avec des composĂ©s Ă  base de Au et Pt. Pour cela, diffĂ©rents types de chromatographie d'affinitĂ©, tels que l'IMAC ou l'hĂ©parine, seuls ou en sĂ©quence, ont Ă©tĂ© revisitĂ©s. L'accent a Ă©tĂ© mis sur l'optimisation des Ă©tapes de concentration inter-chromatographie et le suivi de la rĂ©cupĂ©ration de SELENOP. DiffĂ©rentes conditions chromatographiques ont Ă©tĂ© testĂ©es pour obtenir la meilleure rĂ©solution et sĂ©paration Ă  chaque Ă©tape et augmenter le recouvrement Ă  chaque Ă©tape de la purification.Un Ă©lĂ©ment inhĂ©rent Ă  la thĂšse a Ă©tĂ© une caractĂ©risation approfondie de la sĂ©lĂ©noprotĂ©ine isolĂ©e par spectromĂ©trie de masse haute rĂ©solution et haute prĂ©cision. Aussi Ă©trange que cela puisse paraĂźtre, trĂšs peu de preuves de spectromĂ©trie de masse pour les donnĂ©es de sĂ©quence d'acides aminĂ©s de SELENOP existent dans la littĂ©rature. Par consĂ©quent, une mĂ©thode basĂ©e sur la digestion trypsique et la spectromĂ©trie HPLC MS/MS a dĂ» ĂȘtre dĂ©veloppĂ©e afin de dĂ©montrer l'identitĂ© chimique de la protĂ©ine isolĂ©e et purifiĂ©e et d'acquĂ©rir un support de bases pour l'interprĂ©tation des donnĂ©es sur les interactions de SELENOP avec les composĂ©s Ă  base de Pt et d’Au.L'objectif ultime relatif Ă  SELENOP a Ă©tĂ© d'Ă©tudier sa liaison avec l'auranofine et le cisplatine, en sondant la formation des composĂ©s mĂ©talliques SELENOP et en acquĂ©rant des preuves molĂ©culaires sur les sites de liaison avec l'Au et le Pt.La propension des rĂ©sidus de SeCys Ă  s’oxyder pour former des liaisons Se-Se ou Se-S soulĂšve une question importante sur leur rĂ©activitĂ© avec les mĂ©tallomĂ©dicaments. Alors qu'il est maintenant bien documentĂ© que l'auranofine et ses analogues se lient rapidement et Ă©troitement aux protĂ©ines portant des cystĂ©ines ou des sĂ©lĂ©nocystĂ©ines libres, la capacitĂ© de ces composĂ©s Ă  base d'or d’interagir directement avec les ponts disulfure et disĂ©lĂ©niure et Ă  les cliver est beaucoup moins comprise. Cela nous a incitĂ© Ă  Ă©tudier en dĂ©tail les rĂ©actions de l'auranofine et de ses analogues avec des molĂ©cules modĂšles contenant des motifs disulfures et disĂ©lĂ©niure.Pour cela, nous avons dĂ©cidĂ© d'utiliser, en tant que peptides modĂšles, l’hormone vasopressine (AVP), connue pour son action antidiurĂ©tique et vasopressive, et son analogue sĂ©lĂ©niĂ©e, la selenovasopressine ([Se-Se]-AVP), dans lequel le pont disulfure a Ă©tĂ© remplacĂ© par un pont diselenide tout en gardant l’affinitĂ© de AVP envers le rĂ©cepteur de la vasopressine

    Studies of interaction of selenoprotein P and selenized vasopressin in presence of auranofin and cisplatin

    No full text
    L'un des objectifs de cette thĂšse a Ă©tĂ© de revisiter les schĂ©mas d'isolement de SELENOP rapportĂ©s ailleurs afin de dĂ©velopper une mĂ©thode capable de produire des quantitĂ©s suffisantes de SELENOP pour produire des signaux spĂ©cifiques aux espĂšces de Se mesurables pour des Ă©tudes par spectromĂ©trie de masse des interactions de SELENOP avec des composĂ©s Ă  base de Au et Pt. Pour cela, diffĂ©rents types de chromatographie d'affinitĂ©, tels que l'IMAC ou l'hĂ©parine, seuls ou en sĂ©quence, ont Ă©tĂ© revisitĂ©s. L'accent a Ă©tĂ© mis sur l'optimisation des Ă©tapes de concentration inter-chromatographie et le suivi de la rĂ©cupĂ©ration de SELENOP. DiffĂ©rentes conditions chromatographiques ont Ă©tĂ© testĂ©es pour obtenir la meilleure rĂ©solution et sĂ©paration Ă  chaque Ă©tape et augmenter le recouvrement Ă  chaque Ă©tape de la purification.Un Ă©lĂ©ment inhĂ©rent Ă  la thĂšse a Ă©tĂ© une caractĂ©risation approfondie de la sĂ©lĂ©noprotĂ©ine isolĂ©e par spectromĂ©trie de masse haute rĂ©solution et haute prĂ©cision. Aussi Ă©trange que cela puisse paraĂźtre, trĂšs peu de preuves de spectromĂ©trie de masse pour les donnĂ©es de sĂ©quence d'acides aminĂ©s de SELENOP existent dans la littĂ©rature. Par consĂ©quent, une mĂ©thode basĂ©e sur la digestion trypsique et la spectromĂ©trie HPLC MS/MS a dĂ» ĂȘtre dĂ©veloppĂ©e afin de dĂ©montrer l'identitĂ© chimique de la protĂ©ine isolĂ©e et purifiĂ©e et d'acquĂ©rir un support de bases pour l'interprĂ©tation des donnĂ©es sur les interactions de SELENOP avec les composĂ©s Ă  base de Pt et d’Au.L'objectif ultime relatif Ă  SELENOP a Ă©tĂ© d'Ă©tudier sa liaison avec l'auranofine et le cisplatine, en sondant la formation des composĂ©s mĂ©talliques SELENOP et en acquĂ©rant des preuves molĂ©culaires sur les sites de liaison avec l'Au et le Pt.La propension des rĂ©sidus de SeCys Ă  s’oxyder pour former des liaisons Se-Se ou Se-S soulĂšve une question importante sur leur rĂ©activitĂ© avec les mĂ©tallomĂ©dicaments. Alors qu'il est maintenant bien documentĂ© que l'auranofine et ses analogues se lient rapidement et Ă©troitement aux protĂ©ines portant des cystĂ©ines ou des sĂ©lĂ©nocystĂ©ines libres, la capacitĂ© de ces composĂ©s Ă  base d'or d’interagir directement avec les ponts disulfure et disĂ©lĂ©niure et Ă  les cliver est beaucoup moins comprise. Cela nous a incitĂ© Ă  Ă©tudier en dĂ©tail les rĂ©actions de l'auranofine et de ses analogues avec des molĂ©cules modĂšles contenant des motifs disulfures et disĂ©lĂ©niure.Pour cela, nous avons dĂ©cidĂ© d'utiliser, en tant que peptides modĂšles, l’hormone vasopressine (AVP), connue pour son action antidiurĂ©tique et vasopressive, et son analogue sĂ©lĂ©niĂ©e, la selenovasopressine ([Se-Se]-AVP), dans lequel le pont disulfure a Ă©tĂ© remplacĂ© par un pont diselenide tout en gardant l’affinitĂ© de AVP envers le rĂ©cepteur de la vasopressine.Selenium is known to be an essential trace element with antioxidant activities. Its physiological role is mainly due to its co-translational incorporation into selenoproteins as selenocysteine (SeCys), referred to as the 21st amino acid. selenoprotein P (SELENOP) is the major selenoprotein in plasma with up to 10 SeCys in its sequence. Because of the chemical complexity of the serum matrix, the low abundance of selenoprotein P, and the occurrence of its putative multiple isoforms and post-translational modifications (e.g., glycosylation, Se-S and Se-Se bridges), the characterization of selenoprotein P requires the protein selective pre-concentration and custom-designed optimization of analytical methodology. Containing 10 SeCys residues, SELENOP is a potential preferential target for metallodrugs such as auranofin and cisplatin. The interactions have not been studied yet at the molecular level, despite considerable evidence that free selenols are biding sites for auranofin in another selenoprotein, thioredoxin reductase. The lack of studies of selenoprotein P is likely due to the fact that the protein cannot be heterologously expressed and needs to be purified from serum where it is present at ng/g concentration (as Se). This thesis presents the development of the method of purification of SELENOP from human serum using two-dimensional affinity chromatography. The two chromatographic steps using immobilized metal (cobalt) affinity and heparin affinity chromatography allowed the purification of SELENOP with excellent selectivity. The subsequent characterization of the purified SELENOP by nanoHPLC - electrospray ESI MS/MS allowed accounting for almost all selenocysteine-containing tryptic SELENOP peptides and the elucidation of some glycosylation sites. In addition, the recovery of selenium incorporated in SELENOP was quantitatively monitored, for the first time, at each step of the purification procedure. The recovery of SELENOP was 14% after all the purification steps. Selenium present in SELENOP was found to account for 35% of total selenium in serum.The purification of SELENOP allowed the first study of its interactions with auranofin and cisplatin containing, Au(I) and Pt(II), respectively. The protein metalation was observed after incubation of SELENOP with both metallodrugs. After digestion with trypsin, Au and Pt modifications were observed on the resulting peptides. Either in the case of auranofin and cisplatin, two SELENOP peptides were found to form Au or Pt adducts by Cy and SeCys binding (MS/MS characterization). These four peptides, specific to SELENOP, displayed different sequences.Moreover, to comparatively study the interactions of the Se-Se and S-S bridges with metallodrugs, vasopressin and its di-selenide analogues were used as model peptides. Their reactivity with auranofin and its strict analogues was investigated by LC-electrospray MS/MS. Evidence was obtained of the possible cleavage of the S-S and Se-Se bridges induced by Au(I) in the absence of reducing agents, in contrast to the previous studies requiring a prior reduction of the Se-Se bond to make it react with Au(I) compounds. In addition, we found that at high temperatures (70 °C), the sulfur and selenium atoms were metallated with the preferential binding of gold to selenium, the reaction not taking place under physiological conditions (37 °C)

    Resveratrol-Induced Xenophagy Promotes Intracellular Bacteria Clearance in Intestinal Epithelial Cells and Macrophages

    No full text
    International audienceAutophagy is a lysosomal degradation process that contributes to host immunity by eliminating invasive pathogens and the modulating inflammatory response. Several infectious and immune disorders are associated with autophagy defects, suggesting that stimulation of autophagy in these diseases should be bene ficial. Here, we show that resveratrol is able to boost xenophagy, a selective form of autophagy that target invasive bacteria. We demonstrated that resveratrol promotes in vitro autophagy-dependent clearance of intracellular bacteria in intestinal epithelial cells and macrophages. These results were validated in vivo using infection in a transgenic GFP-LC3 zebra fish model. We also compared the ability of resveratrol derivatives, designed to improve the bioavailability of the parent molecule, to stimulate autophagy and to induce intracellular bacteria clearance. Together, our data demonstrate the ability of resveratrol to stimulate xenophagy, and thereby enhance the clearance of two invasive bacteria involved life-threatening diseases, Salmonella Typhimurium and Crohn's disease-associated Adherent-Invasive Escherichia coli. These findings encourage the further development of pro-autophagic nutrients to strengthen intestinal homeostasis in basal and infectious states

    Identification of Three-Way DNA Junction Ligands through Screening of Chemical Libraries and Validation by Complementary in Vitro Assays.

    Get PDF
    International audienceThe human genome is replete with repetitive DNA sequences that can fold into thermodynamically stable secondary structures such as hairpins and quadruplexes. Cellular enzymes exist to cope with these structures whose stable accumulation would result in DNA damage through interference with DNA transactions such as transcription and replication. Therefore, the chemical stabilization of secondary DNA structures offers an attractive way to foster DNA transaction-associated damages to trigger cell death in proliferating cancer cells. While much emphasis has been recently given to DNA quadruplexes, we focused here on three-way DNA junctions (TWJ) and report on a strategy to identify TWJ-targeting agents through a combination of in vitro techniques (TWJ-screen, polyacrylamide gel electrophoresis, fluorescence resonance energy transfer-melting, electrospray ionization mass spectrometry, dialysis equilibrium, and sulforhodamine B assays). We designed a complete workflow and screened 1200 compounds to identify promising TWJ ligands selected on stringent criteria in terms of TWJ-folding ability, affinity, and selectivity
    corecore